David Rosen – SPRY history
- Issuer:
- ARS PHARMACEUTICALS INC
- Quarters tracked:
- 15 (Q3 2022 → Q2 2026)
- Current shares:
- 8,540,861
- Current value:
- $68.41M
- Peak shares:
- 8,540,861 (Q2 2026)
- Overall change:
- +217%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 8,540,861 | $68.41M | $8.01 | +540,861 | +7% |
| Q1 2026 | 8,000,000 | $64.24M | $8.03 | +1,800,000 | +29% |
| Q4 2025 | 6,200,000 | $72.23M | $11.65 | +1,700,000 | +38% |
| Q3 2025 | 4,500,000 | $45.23M | $10.05 | +3,205,122 | +248% |
| Q2 2025 | 1,294,878 | $22.60M | $17.45 | +265,777 | +26% |
| Q1 2025 | 1,029,101 | $12.95M | $12.58 | +1,029,101 | +100% |
| Q3 2024 | SOLD | — | — | -639,203 | -100% |
| Q2 2024 | 639,203 | $5.44M | $8.51 | 0 | 0% |
| Q1 2024 | 639,203 | $6.53M | $10.22 | 0 | 0% |
| Q4 2023 | 639,203 | $3.50M | $5.48 | 0 | 0% |
| Q3 2023 | 639,203 | $2.42M | $3.78 | -2,160,000 | -77% |
| Q2 2023 | 2,799,203 | $18.75M | $6.70 | -681,509 | -20% |
| Q1 2023 | 3,480,712 | $22.66M | $6.51 | +490,148 | +16% |
| Q4 2022 | 2,990,564 | $25.51M | $8.53 | +295,394 | +11% |
| Q3 2022 | 2,695,170 | $14.23M | $5.28 | — | NEW |